http://www.fpnotebook.com/
OxazepamAka: Serax
- See Also
- Indications
- Anxiety Disorder
- Anxiety with comorbid Major Depression
- Alcohol Withdrawal
- Class
- Short acting Benzodiazepine
- Pharmacokinetics
- Half Life: 8 hours
- Dosing
- Dose: 10 to 30 mg PO tid to qid
- Maximum Daily Dose: 120 mg
- Equivalent dosing (for Benzodiazepine Withdrawal)
- Valium = Dose x1.0
- Phenobarbital = Dose x3.0
Oxazepam (C0029997) | |
|---|---|
| Definition (MSH) | A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. |
| Definition (CSP) | benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. |
| Definition (NCI) | A synthetic benzodiazepine derivative with anxiolytic and sedative hypnotic properties. Although the mechanism of action has not been fully elucidated, oxazepam appears to enhance gamma-aminobutyric acid (GABA) receptor affinity for GABA, thereby prolonging synaptic actions of GABA. |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D010076 |
| English | Oxazepam, OXAZEPAM PREPARATION, Ro 5-6789, Seresta, Wy 3498 |
| Spanish | oxacepam, oxazepam |
| Parent Concepts | Benzodiazepinones (C0005065), Benzodiazepines (C0005064), Tranquilizing Agents (C0040614), [CN302] BENZODIAZEPINE DERIVATIVE, SEDATIVES/HYPNOTICS (C0973503), Benzodiazepine sedative (C0360114) |
| Sources | AOD, CSP, LNC, MSH, MTH, MTHFDA, MTHSPL, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Serax (C0702214) | |
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D010076 |
| English | Serax |
| Sources | AOD, MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |
